Apart from the funding angle we touched upon yesterday I guess...

Apart from the funding angle we touched upon yesterday I guess another thing holding back rocket ship ANP is the uncertainty of the small add-on trial to test higher doses. How long will it take and does it impact the timing of the Phase 3. I'd be disappointed if they cant get a P3 trial going by say no later than June next year. I'm also wondering how much ATL-1103 product they have left in the inventory, and how long it would take to manufacture a new batch. Hopefully Mark can clear up the details of the small add-on trial post P2 results. Here's hoping the share price opens at 20c if results come in at 30%.